Collectively, regarding chromosomal aberrations at these two cancer-related loci, every examined carcinoma including the two cell lines contained either the Met amplification or the Cdkn2a/2b deletion (Table 1, Figs. 2B and 3B). The gene discussed is CDKN2A; the disease is carcinoma.